Hyaluronic acid (HA) dermal fillers are the dominant aesthetic-injectable category for volume restoration, contouring, and wrinkle correction in Indian aesthetic dermatology practice. The market is dominated by three US/EU-approved brand families:
Allergan Juvederm uses proprietary Vycross technology that cross-links HA molecules for greater longevity and smoother gel texture. Product range: Volbella (lips, fine lines, 9-12 months), Volift (nasolabial folds, 12-15 months), Voluma (cheek volume, 18-24 months, the longest HA durability on the market). India 2026 pricing: ₹25,000-70,000 per 1 mL syringe.
Galderma Restylane has 25+ years on market, the longest safety track record. Product range: Restylane Kysse (lips), Restylane Refyne / Defyne (facial wrinkles), Restylane Lyft (cheek + jawline lift), Restylane Volyme (midface volume). India 2026: ₹20,000-50,000 per 1 mL syringe.
Merz Belotero is known for exceptionally smooth tissue integration, particularly suited for superficial fine lines + delicate areas (under-eye, lip border, fine forehead lines). India 2026: ₹18,000-40,000 per 1 mL syringe.
DermaVue Kochi practice: dermatologist-led brand selection per treatment zone (Voluma for cheek architecture, Volbella for lip border refinement, Belotero for under-eye fine lines); MD DVL administration only; complication protocol includes hyaluronidase 150-300 IU on-hand for vascular emergency dissolution. Typical treatment volumes, lip enhancement 0.5-1 mL, nasolabial 1-2 mL, cheek 1-2 mL per side, jawline 2-4 mL per side. Lower-tier alternatives (Indian-manufactured + Korean HA brands like Princess, Stylage) are 30-50% cheaper but with shorter durability and less peer-reviewed safety data.